Joinn Laboratories(China)Co.,Ltd. (6127.HK)
HKD 9.01
(-0.99%)
HKD 9.01
(-0.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 622.87 Million | 971.06 Million | 685.65 Million | 428.38 Million | 148.09 Million | 176.07 Million |
| Net Income | 391.55 Million | 1.07 Billion | 556.41 Million | 313.62 Million | 178.21 Million | 108.18 Million |
| Depreciation & Amortization | 129.51 Million | 120.95 Million | 96.43 Million | 60.65 Million | 42.36 Million | 29.05 Million |
| Deferred income taxes | 277.81 Million | 1.43 | -171.73 Million | -61.37 Million | -11.65 Million | - |
| Stock-based compensation | 6.02 Million | 9.58 Million | 23.51 Million | 29.9 Million | 11.65 Million | 8.27 Million |
| Change in working capital | -126.83 Million | 181.92 Million | 158.75 Million | 86.33 Million | -84.14 Million | 51.16 Million |
| Other non-cash items | -55.2 Million | -414.6 Million | 22.26 Million | -757.04 Thousand | 11.65 Million | -12.33 Million |
| Investing Cash Flow | -315.42 Million | -2.16 Billion | -2.06 Billion | -254.9 Million | -102.09 Million | -269.52 Million |
| Investments in PPE | -192.72 Million | -274.84 Million | -237.24 Million | -148.97 Million | -126.77 Million | -129.92 Million |
| Acquisitions | -90.05 Million | -1.68 Billion | 1.05 | 186.49 Thousand | -192.24 Million | 129.92 Million |
| Investment purchases | -647.35 Million | -1.09 Billion | -2.62 Billion | -444 Million | -1.2 Billion | -773.96 Million |
| Sales/Maturities of investments | 606.34 Million | 907.4 Million | 789.3 Million | 341.53 Million | 1.42 Billion | 634.36 Million |
| Other Investing Activities | 8.35 Million | -13.44 Million | 246.52 Thousand | -3.64 Million | 12.55 Thousand | -129.92 Million |
| Financing Cash Flow | -361.67 Million | -99.33 Million | 5.29 Billion | -36.87 Million | -15.4 Million | -15.29 Million |
| Debt repayment | -6.89 Million | -58.87 Million | -3.72 Million | -31.78 Million | -12.48 Million | - |
| Dividends payments | -214.33 Million | -137.71 Million | -95.27 Million | -55.81 Million | -34.56 Million | -24.64 Million |
| Common Stock Repurchased | -113.58 Million | -23.78 Million | -654.98 Thousand | - | - | - |
| Common Stock Issuance | - | 23.78 Million | 654.98 Thousand | - | - | - |
| Other Financing Activities | -140.45 Million | 97.25 Million | 5.38 Billion | 50.71 Million | 31.64 Million | 9.35 Million |
| Accounts receivables | -91.41 Million | -127.68 Million | -64.83 Million | -18.79 Million | -61.42 Million | -29.76 Million |
| Accounts payables | 91.41 Million | 127.68 Million | 64.83 Million | 18.79 Million | 61.42 Million | - |
| Inventory | 239.35 Million | -182.45 Million | -226.74 Million | -139.96 Million | -65.31 Million | -23.79 Million |
| Other working capital | -366.19 Million | 364.37 Million | 385.49 Million | 226.3 Million | -18.83 Million | 74.95 Million |
| Cash at beginning of period | 2.89 Billion | 4.15 Billion | 305.04 Million | 176.95 Million | 148.69 Million | 254.61 Million |
| Cash at end of period | 2.85 Billion | 2.89 Billion | 4.15 Billion | 305.04 Million | 176.95 Million | 148.69 Million |
| Capital Expenditure | -192.72 Million | -274.84 Million | -237.24 Million | -148.97 Million | -126.77 Million | -129.92 Million |
| Effect of forex changes on cash | 8.4 Million | 37.46 Million | -60.89 Million | -8.52 Million | -2.32 Million | 2.81 Million |
| Net cash flow / Change in cash | -45.82 Million | -1.25 Billion | 3.84 Billion | 128.08 Million | 28.26 Million | -105.92 Million |
| Free Cash Flow | 430.15 Million | 696.22 Million | 448.41 Million | 279.4 Million | 21.31 Million | 46.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 102.47 Million | -272.22 Million | 69.39 Million | 391.55 Million | 236.97 Million | -97.13 Million |
| Depreciation & Amortization | 72.47 Million | - | 124.76 Million | 129.51 Million | -62.42 Million | 62.42 Million |
| Deferred income taxes | - | - | 2.00 | 277.81 Million | 12.51 Million | -12.51 Million |
| Stock-based compensation | - | - | 6.02 Million | 6.02 Million | -3.15 Million | 3.15 Million |
| Change in working capital | 92.66 Million | - | 147.94 Million | -126.83 Million | -9.35 Million | 9.35 Million |
| Other non-cash items | -229.84 Million | 392.17 Million | -173.69 Million | -55.2 Million | 27.68 Million | 294.58 Million |
| Investing Cash Flow | -678.1 Million | -67.56 Million | -178.28 Million | -315.42 Million | -94.84 Million | -148.78 Million |
| Investments in PPE | -71.01 Million | -59.01 Million | -43.07 Million | -192.72 Million | -45.6 Million | -48.17 Million |
| Acquisitions | - | - | 48.71 Thousand | -90.05 Million | 0.59 | -90.02 Million |
| Investment purchases | -2.41 Billion | -120 Million | -221.27 Million | -647.35 Million | -251.07 Million | -115 Million |
| Sales/Maturities of investments | 1.8 Billion | 102.25 Million | 82.22 Million | 606.34 Million | 201.77 Million | 113.6 Million |
| Other Investing Activities | -607.09 Million | 9.2 Million | 3.78 Million | 8.35 Million | 57.87 Thousand | -9.19 Million |
| Financing Cash Flow | -69.32 Million | -37.92 Million | -28.38 Million | -361.67 Million | -239.68 Million | -68.75 Million |
| Debt repayment | - | - | -21.52 Thousand | -6.89 Million | -58.01 Thousand | -5.95 Million |
| Dividends payments | - | - | -269.44 | -214.33 Million | -214.24 Million | -30.24 Thousand |
| Common Stock Repurchased | -92.92 Million | - | -113.58 Million | -113.58 Million | - | -73 Million |
| Common Stock Issuance | - | - | - | - | - | 73 Million |
| Other Financing Activities | -69.32 Million | -37.92 Million | -28.36 Million | -140.45 Million | -25.38 Million | -62.76 Million |
| Accounts receivables | 3.17 Million | - | -91.41 Million | -91.41 Million | -26.25 Million | 26.25 Million |
| Accounts payables | - | - | - | 91.41 Million | - | - |
| Inventory | 89.48 Million | - | 239.35 Million | 239.35 Million | 16.9 Million | -16.9 Million |
| Other working capital | - | - | - | -366.19 Million | - | - |
| Cash at beginning of period | 2.86 Billion | 2.85 Billion | 2.89 Billion | 2.89 Billion | 3.02 Billion | 2.96 Billion |
| Cash at end of period | 2.15 Billion | 2.86 Billion | 2.85 Billion | 2.85 Billion | 2.89 Billion | 3.02 Billion |
| Capital Expenditure | -71.01 Million | -59.01 Million | -43.07 Million | -192.72 Million | -45.6 Million | -48.17 Million |
| Effect of forex changes on cash | 2.54 Million | -2.79 Million | -5.39 Million | 8.4 Million | -3.97 Million | 24.05 Million |
| Net cash flow / Change in cash | -707.11 Million | 11.66 Million | -37.62 Million | -45.82 Million | -136.27 Million | 66.39 Million |
| Free Cash Flow | -33.24 Million | 60.93 Million | 131.36 Million | 430.15 Million | 156.62 Million | 211.7 Million |
4550
7647
CAAS
002593
7762
LNW